COVID-19 and Short- and Medium-term Outcomes in Liver Transplant Patients: A Spanish Single-center Case Series

• DOI: 10.1016/j.jceh.2021.05.009
• Publication Date: 2021-05-31T15:59:11Z
• Authors: Javier Tejedor-Te...; Esteban Fuentes-V...; Carmen Alonso-Martin; Carolina Almohall...; Felix Garcia-Pajares
• Keywords: Immunosuppression; Single Center; Liver function

The evidence suggests that most vulnerable subjects to COVID-19 infection suffer from patients with comorbidities or immunosuppression, including liver transplant recipients. Liver graft dysfunction may be a rare complication. Some complain about the post-COVID-19 syndrome. aim of this study was assess medium- and short-term outcomes in patients.A retrospective case series performed at tertiary referral center. We screened 845 who had (LT) our All consecutive LT during Spanish outbreak March 2020 April 2021 were included. Demographics, pre-existing comorbidities, clinical radiological data infection, complications, function assessed diagnosis 3-month follow-up.Overall, 20 diagnosed confirmed COVID-19. included 16 met inclusion criteria, 8 nonhospitalized (50%) hospitalized analyzed. median follow-up 5.33 months (IQR 3.06-8.26). One patient died follow-up. presented some grade respiratory functional symptoms. Dyspnea fatigue prevalent symptoms No reported despite partial immunosuppression withdrawal four (25%). cardiovascular complications.Our results suggest presence syndrome mild residual physical psychological subgroup 3 after However, no cases loss reported.